Delivery Order SPE2DB22D3016-SPE2DB25FAWD2

Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $10,567.60 and is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 18, 2025. The place of performance is Conshohocken, Pennsylvania. This contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,499.34, is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 100 MG TABLET UU 120S. The contract has a firm fixed price of $21,039.24 and a completion date of June 4, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product LYNPARZA 100 MG TABLET. The award has a ceiling value of $39,357.76 and an ultimate completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a $10,567.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,654.82, is for the delivery of Lynparza 150 mg tablets over the period ending on April 7, 2025. The contract is a firm-fixed-price, delivery order type, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,565,333,142 units of the prescription drug LYNPARZA 150 MG TABLET. The contract has a ceiling value of $9,870.87 and an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of May 2, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has a firm fixed price of $39,098.88 and a completion date of January 24, 2024. It is a delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of Lynparza 150 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWD2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 150 MG TABLET UU 120S. The contract has a ceiling value of $42,438.84 and is a firm fixed price contract with a period of performance through June 3, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is likely part of the company's broader efforts to supply a wide range of pharmaceutical products and medical supplies to support military and federal government healthcare programs.

Generated 8/17/25, 1:05 AM